PROTON PUMP INHIBITORS AND METHODS OF USE IN CHEMORADIATION-INDUCED TISSUE INFLAMMATION AND SCARRING

Embodiments of the disclosure include methods and compositions related to treatment or prevention of cancer therapy-induced tissue inflammation, dermatitis, and/or scarring. In particular embodimentsone or more proton pump inhibitors are provided to an individual before, during, and/or after receivi...

Full description

Saved in:
Bibliographic Details
Main Authors GHEBRE YOHANNES T, BONNEN MARK D, LUDWIG MICHELL S, JHAVERI PAVAN M
Format Patent
LanguageChinese
English
Published 02.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Embodiments of the disclosure include methods and compositions related to treatment or prevention of cancer therapy-induced tissue inflammation, dermatitis, and/or scarring. In particular embodimentsone or more proton pump inhibitors are provided to an individual before, during, and/or after receiving anticancer therapy. In some embodiments one or more proton pump inhibitors are provided to an individual before, during, and/or after having a health conditions, allergies, genetic factors and/or exposure to one or more irritants. 本公开的实施方案包括涉及治疗或预防癌症疗法诱发的组织炎症、皮炎和/或瘢痕的方法和组合物。在具体的实施方案中,将一种或多种质子泵抑制剂在接受抗癌疗法之前、期间和/或之后提供给个体。在一些实施方案中,将一种或多种质子泵抑制剂在具有健康状况、变态反应、遗传因素和/或暴露于一种或多种刺激物之前、期间和/或之后提供给个体。
Bibliography:Application Number: CN201980027380